Journals / Türkiye Aile Hekimliği Dergisi / 2018 / Cilt: 22 - Sayı: 4

Erratum: Inhaler device usage skills in patients at pulmonology clinics

Düzeltme: Göğüs hastalıkları polikliniğine başvuran hastaların inhaler kullanım becerilerinin araştırılması

Pages
0–0
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Correct utilization rate was 66.3% for Metered Dose Inhaler (MDI) and, it was ranged from 76-81% for Dry Powder Inhaler(DPI) (p=0.030, p60 years old), to be literate or graduated from primary school, duration of symptoms (60 years old), to be literate, being graduated from primary school, duration of symptoms (

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: In the treatment of obstructive lung diseases, large number of drugs (both bronchodilator and antiinflammatory drugs) have been used by inhalation.
📊
Key Findings & Data:Materials and Method: Patients who were followed up in Ümraniye Training and Research Hospital Chest Diseases Department between 01.06.2010- 30.12.2010 for asthma and/or chronic obstructive pulmonary disease were retrospectively evaluated.
💡
Conclusion & Impact:Correct utilization rate was 66.3% for Metered Dose Inhaler (MDI) and, it was ranged from 76-81% for Dry Powder Inhaler(DPI) (p=0.030, p60 years old), to be literate or graduated from primary school, duration of symptoms (60 years old), to be literate, being graduated from primary school, duration of symptoms (
🔬Design:Research Article
📍Scope:2010 Verileri
⚙️Variables:Domain Parameters

Abstract

Aim: In the treatment of obstructive lung diseases, large number of drugs (both bronchodilator and antiinflammatory drugs) have been used by inhalation. Due to the errors made during inhaler drug administration patients either don’t take targeted doses, or even any medication. In the present study we aimed to determine factors affecting the correct use of inhaler devices. Materials and Method: Patients who were followed up in Ümraniye Training and Research Hospital Chest Diseases Department between 01.06.2010- 30.12.2010 for asthma and/or chronic obstructive pulmonary disease were retrospectively evaluated. All the patients received inhaler drug treatment previously. The ability to use inhaler drugs and causative factors for improper use were investigated. The study included 751 patients (M/F: 254/497). Patients’ age, gender, education level, duration of symptoms and the devices used were achieved from the records. Using skills were evaluated according to the chart prepared by the Turkish Respiratory Society “Inhalation Therapies” Working Study Group. Results: Seventy-four percent of patients were using their drugs correctly. Correct utilization rate was 66.3% for Metered Dose Inhaler (MDI) and, it was ranged from 76-81% for Dry Powder Inhaler(DPI) (p=0.030, p60 years old), to be literate or graduated from primary school, duration of symptoms (60 years old), to be literate, being graduated from primary school, duration of symptoms (

Özet

Amaç: Obstrüktif akciğer hastalıklarının tedavisinde, bronkodilatör ve anti-inflamatuvar ilaçlar çoğunlukla inhalasyon yolu ilekullanılmaktadır. İnhaler ilaç uygulamasında görülen hatalar, hastaların hedeflenen dozlarda ilaç alamamalarına hatta tedavisiz kalmalarına neden olabilmektedir. Bu çalışmada inhaler cihazların doğru kullanımını etkileyen faktörlerin belirlenmesi hedeflenmiştir.Gereç ve Yöntem: Çalışmamızda 01.06.2010-30.12.2010 tarihleri arasında Ümraniye Eğitim ve Araştırma Hastanesi GöğüsHastalıkları polikliniğine başvuran daha önce astım/KOAH tanısıyla inhaler tedavi verilmiş hastaların, retrospektif olarak inhaler ilaç kullanma becerileri değerlendirilerek hatalı kullanımaetki eden faktörler araştırıldı. Çalışmaya inhaler cihaz kullanmakta olan 751 hasta (E/K: 254/497) alındı. Hastaların yaş, cinsiyet, eğitim durumu, yakınma süresi, kullanılan cihaz bilgileri veinhaler cihazlarını kullanma yöntemleri kayıtlardan elde edildi.Kullanım becerileri, Türkiye Solunum Araştırmaları Derneği “İnhalasyon Tedavileri” Çalışma Grubunun hazırladığı inhaler ilaçkullanma beceri çizelgesine göre değerlendirildi.Bulgular: Hastaların %74’ü ilaçlarını doğru olarak kullanmaktaydı. Doğru kullanım oranları ölçülü doz inhaler (ÖDİ)’de%66,3 ve kuru toz inhalerde (KTİ) %76-81 arasında değişmekteydi (p:0.030, p

🔖

Cite This Article

Sarıman, N., Şaylan, B., Başlılar, Ş., Oludağ, G. (2022). Erratum: Inhaler device usage skills in patients at pulmonology clinics. Türkiye Aile Hekimliği Dergisi, Cilt: 22 - Sayı: 4, 0–0. https://ajindex.com/articles/626684

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (19)

  1. Global Strategy for Asthma Management and Prevention 2011 (update). www.ginasthma.org
  2. Masoli M, Fabian D, Holt S, Beasley R. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy 2004; 59(5):469-78
  3. Beasley R. The global burden of asthma (GINA). Available from http//www.ginasthma.org 2004
  4. Jeffrey PK. Remodelling in asthma and chronic obstructive lung disease. Am J Respir Crit Care Med 2001; 164: S28-38
  5. Hogg JC, Chu F, Utokaparch S, et al. The nature of small airway obstruction in chronic obstructive lung disease. N Engl J Med 2004; 350: 2645-53
  6. Fabri LM, Romagnoli M, Corbetta L, et al. Differences in airway inflamation in patients with fixed airflow obstruction due to asthma or chronic obstructive lung disease. Am J Respir Crit Care Med 2003; 167: 418-24
  7. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease 2009 (www.goldcopd.org
  8. Türk Toraks Derneği Kronik Obstruktif Akciğer Hastalığı Tanı ve Tedavi Uzlaşı Raporu 2010
  9. Scheuch G, Kohlhaeufl MJ, Brand P, Siekmeier R. Clinical perspectives on pulmonary systemic and macromolecular delivery. Adv Drug Deliv Rev 2006; 58(9-10): 996-1008
  10. Dolovich MB, Dhand R. Aerosol drug delivery: developments in device design and clinical use. Lancet 2011;19(377): 1032-45
  11. Erk M. İnhalasyon teknikleri. Toraks Dergisi 2002; 3: 7-13
  12. Rau JL. Practical problems with aerosol therapy in COPD. Respir Care 2006; 51: 158-72
  13. Fink JB, Rubin BK. Problems with inhaler use: a call for improved clinician and patient education. Respir Care 2005; 50: 1360-74; discussion 1374-75
  14. King D, Earnshaw SM, Delaney JC. Pressurised aerosol inhalers: the cost of misuse. Br J Clin Pract 1991; 45:48-9
  15. Aydemir Y. İnhaler cihazların hatalı kullanımı-Etkili faktörler ve eğitimin rolü. Solunum 2013; 15(1):32-8
  16. Lavorini F, Magnan A, Dubus JC, et al. Effect of incorrect use of dry powder inhalers on management of patients with asthma and COPD. Respir Med 2008;102: 593-604
  17. Chapman KR, Voshaar TH, Virchow JC. Inhaler choice in primary practice. Eur Respir Rev 2005; 96: 117-22
  18. Giraud V, Roche N. Misuse of corticosteroid metered-dose inhaler is associated with decreased asthma stability. Eur Respir J 2002; 19: 246-51
  19. Plaza V, Sanchis J. Medical personnel and patient skill in the use of metered dose inhalers: a multicentric study. CESEA Grou